Aqemia
PrivateLast Round
Grant
Apr 1, 2025
Total Funding Raised
$108.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aqemia is a pharmatech company that utilizes a platform combining generative AI with quantum-inspired physics to accelerate the discovery of small-molecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Quantum Computing, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aqemia Comparables
Compare Aqemia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qubit Pharmaceuticals | 90% | |
| Iktos | 88% | |
| Evariste | 86% |
Aqemia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2025 | ||||
| Early Funding | Dec 10, 2024 | ||||
| Series A Extension | Jan 30, 2024 | ||||
| Series A | Oct 19, 2022 | ||||
| Pre Seed | Oct 17, 2019 |
Key People
Founding team and executive leadership
Aqemia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| Wendel Growth | Series A Extension |
| Elaia Partners | Series A, Early Funding, Series A Extension, Pre Seed |
| Wendel Group | Early Funding |
| Bpifrance | Early Funding, Series A Extension, Pre Seed, Series A |
| Eurazeo | Early Funding, Series A Extension, Series A |
| Cathay Innovation | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Recognized as a key player in Europe's DeepTech ecosystem.
- Apr 21, 2026
Recognized as a key player in Europe's DeepTech ecosystem.
Aqemia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aqemia's valuation, stock price, and market status.
Is Aqemia a public or private company?
Aqemia is a private company.
What is the current stock price of Aqemia?
Aqemia is a private company, so its shares have no public market price. Caplight tracks Aqemia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aqemia worth (valuation)?
Valuation information for Aqemia is not publicly available.
Can I buy Aqemia stock?
Aqemia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aqemia's last funding round?
Aqemia's most recent funding round was Grant on April 1, 2025.
Who are the main investors in Aqemia?
Key investors in Aqemia include Wendel Growth, Elaia Partners, Bpifrance, Eurazeo, Cathay Innovation.
Will Aqemia IPO soon?
No public IPO plans have been announced for Aqemia.
How can I track Aqemia secondary market activity?
Caplight tracks bids, offers, and trades in Aqemia's shares on secondary markets.